Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction
Abstract Doxorubicin, the most prescribed chemotherapeutic drug, causes dose-dependent cardiotoxicity and heart failure. However, our understanding of the immune response elicited by doxorubicin is limited.